Table II.

Details of oral metronomic regimens

Serial number	Regimens used	Dose (mg)	Number of patients (%)
1	Pazopanib-containing regimens		13 (36.1)
1A	VP16 CTx Pazopanib	VP16=50 CTx=50 Pazopanib=200	4 (11.1)
1B	VP16 CTx Pazopanib	VP16=50 CTx=50 Pazopanib=400	7 (19.4)
1C	Pazopanib weekly paclitaxel	Pazopanib=800 Paclitaxel=80 mg/m2	2 (5.6)
2	Non-pazopanib-containing regimens		23 (63.9)
2A	Single-agent VP16	VP16=50	6 (16.7)
2B	Vp16+CTx+celecoxib	VP16=50 CTx=50 Celecoxib=200	4 (11.1)
2C	VP16 CTx	VP16=50 CTx=50	13 (36.1)
	Total		36 (100.0)

CTx, cyclophosphamide; VP-16, etoposide